OptimizeRx Corporation - Common Stock (NQ:OPRX)
7.895
+0.185
(+2.40%)
Streaming Delayed Price
Updated: 12:46 PM EDT, Aug 24, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 55,537 |
| Open | 7.710 |
| Bid (Size) | 7.880 (300) |
| Ask (Size) | 7.910 (400) |
| Prev. Close | 7.710 |
| Today's Range | 7.710 - 8.100 |
| 52wk Range | 4.540 - 22.25 |
| Shares Outstanding | 17,618,607 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
OptimizeRx (OPRX) Q1 2026 Earnings Transcript ↗
May 14, 2026
OptimizeRx Q1 Earnings Call Highlights ↗
May 12, 2026
Discover the top movers in Wednesday's pre-market session. ↗
March 18, 2026
OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript ↗
March 05, 2026
Whetstone Dumps 79,000 monday.com Shares Worth $15.3 Million ↗
February 21, 2026
Frequently Asked Questions
Is OptimizeRx Corporation - Common Stock publicly traded?
Yes, OptimizeRx Corporation - Common Stock is publicly traded.
What exchange does OptimizeRx Corporation - Common Stock trade on?
OptimizeRx Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for OptimizeRx Corporation - Common Stock?
The ticker symbol for OptimizeRx Corporation - Common Stock is OPRX on the Nasdaq Stock Market
What is the current price of OptimizeRx Corporation - Common Stock?
The current price of OptimizeRx Corporation - Common Stock is 7.895
When was OptimizeRx Corporation - Common Stock last traded?
The last trade of OptimizeRx Corporation - Common Stock was at 08/24/26 12:46 PM ET
What is the market capitalization of OptimizeRx Corporation - Common Stock?
The market capitalization of OptimizeRx Corporation - Common Stock is 139.10M
How many shares of OptimizeRx Corporation - Common Stock are outstanding?
OptimizeRx Corporation - Common Stock has 139M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.